Humana (HUM) Projected to Announce Earnings on Wednesday

Humana (NYSE:HUM) will likely be releasing its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to post earnings of $7.26 per share and revenue of $40.5673 billion for the quarter. Humana has set its FY 2026 guidance at 9.000- EPS. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:00 AM ET.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the previous year, the business earned $11.58 EPS. The firm’s revenue was up 23.5% compared to the same quarter last year. On average, analysts expect Humana to post $9 EPS for the current fiscal year and $16 EPS for the next fiscal year.

Humana Stock Down 0.2%

Shares of Humana stock opened at $388.56 on Monday. The stock’s 50-day moving average is $364.10 and its 200 day moving average is $264.93. Humana has a one year low of $163.11 and a one year high of $428.88. The firm has a market cap of $46.65 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 2.12 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Institutional Investors Weigh In On Humana

A number of institutional investors and hedge funds have recently bought and sold shares of HUM. Larson Financial Group LLC boosted its holdings in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares during the last quarter. Fulcrum Asset Management LLP bought a new stake in shares of Humana in the 3rd quarter worth $42,000. DV Equities LLC purchased a new stake in shares of Humana in the fourth quarter valued at about $43,000. BOKF NA lifted its position in shares of Humana by 4,125.0% during the third quarter. BOKF NA now owns 169 shares of the insurance provider’s stock valued at $44,000 after purchasing an additional 165 shares in the last quarter. Finally, Caden Capital Partners LP bought a new position in shares of Humana during the fourth quarter valued at about $112,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have issued reports on HUM shares. Barclays boosted their price target on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Bank of America reiterated a “neutral” rating and set a $410.00 target price on shares of Humana in a research report on Monday, July 20th. Evercore increased their target price on shares of Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. Finally, Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $327.17.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.